Agios Pharmaceuticals
AGIO
#5163
Rank
A$2.38 B
Marketcap
A$40.10
Share price
1.02%
Change (1 day)
-14.40%
Change (1 year)

EPS for Agios Pharmaceuticals (AGIO)

EPS in 2026 (TTM): A-$10.55

According to Agios Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$9.74. In 2021 the company made an earnings per share (EPS) of A$31.16 an increase over its 2020 EPS that were of A-$6.64.

EPS history for Agios Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$10.55
2021A$31.16-569.2%
2020A-$6.64-31%
2019A-$9.6313.93%
2018A-$8.45-10.53%
2017A-$9.4433.47%
2016A-$7.0861.34%
2015A-$4.3998.1%
2014A-$2.21-4.34%
2013A-$2.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.84-118.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$39.55-506.12%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.45-155.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
A-$2.48-74.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$4.39-145.04%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$1.96-120.14%๐Ÿ‡บ๐Ÿ‡ธ USA